We are a biopharmaceutical company based in Germany and manufacturer of cell transplants. With over 30 years of experience in the field of tissue engineering, our focus is on the development, manufacture and distribution of cell therapies for the joint-preserving, minimally invasive treatment of articular cartilage defects using only the body's own cartilage cells. Our mission and passion is to enable patients to live an active life. Since the first treatment in 1997, over 19,000 patients have been treated with CO.DON products.
Since January 2023, CO.DON is part of the ReLive Biotechnologies Group. ReLive is a pioneering global biotechnology company, founded in 2021, that strives to make a lasting impact on the field of biotechnology and cell therapy.
